![Joanne Holland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 84 000 $ in data 31/08/2026
Joanne Holland was the founder of Nuformix Plc, founded in 2008, serving as Executive Director in 2021.
Dr. Holland is currently the Chief Scientific Officer at CDT Equity, Inc., starting in 2024.
Formerly, Director, Chief Scientific & Technology Officer at Nuformix Technologies Ltd. from 2008 to 2021.
Education includes a doctorate from the University of Leeds.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NUFORMIX PLC 1,44% | 28/01/2025 | 37.500.000 ( 1,44% ) | 84 000 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CDT EQUITY INC. | Direttore Tecnico/Scientifico/R&S | 19/03/2024 |
| Società | Posizione | Fine |
|---|---|---|
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 31/05/2021 |
| NUFORMIX PLC | Fondatore | 31/05/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nuformix Plc
 Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
Conduit Pharmaceuticals, Inc.
 Conduit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty biopharmaceutical company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
